Treatment of allergic rhinitis with intranasal infusion of botulinum toxin type A in mice

Conclusions Topical treatment with BTX-A efficiently and temporarily ameliorates AR symptoms. Intranasal infusion does not cause pain or bleeding, and the effects of a single infusion of BTX-A last for at least three weeks. This treatment might be a promising therapeutic strategy for the treatment of AR.
Source: Life Sciences - Category: Biology Source Type: research